|
|
|
市場調查報告書
全球胎兒監測、診斷及預測試驗市場
Fetal Monitoring, Diagnostics and Predictive Tests
| 出版商 |
BCC Research |
| 出版日期 |
2011年04月 |
商品編碼 |
193693 |
| 內容資訊 |
英文 145 Pages |
| 價格 |
|
|
全球胎兒監測、診斷及預測試驗市場 是由出版商BCC Research在2011年04月所出版的。
這份英文市場調查報告書包含145 Pages 價格從美金4850起跳。
2010年全球胎兒監測、診斷及預測試驗市場約達62億美金規模。預計本市場今後將可以4.4%之CAGR成長，於2016年達到80億美金規模。而創下2010年53億美金銷售之最大市場區隔產前診斷，因受到高安全性及非侵入式胎兒DNA診斷技術導入之帶動，預計將可有CAGR4.3%之穩定成長。
本報告為，調查分析全球胎兒監測、診斷及預測試驗市場現況及展望，並匯整產品區隔、應用及地區別表現與預測（∼2016年）、產品區隔別主要製造商、供應商市場佔有率、相關法規、專利數據、未來展望、主要企業簡介等，以下列摘要形式闡述。
第1章 簡介
第2章 實施概要
第3章 概要
第4章 法規
第5章 分類
第6章 基因疾病檢測
- 顯性遺傳疾病
- 隱性遺傳疾病
- X連鎖遺傳疾病
- 染色體異常
第7章 產業結構
- 胎兒監視器及診斷器之製造商、供應商
- 胎兒監視系統及診斷之領導企業市場佔有率
第8章 新發展
第9章 市場分析
第10章 應用別市場
- 產前胎兒監測
- 產中胎兒監測
- 新生兒心肺疾病監測
- 應用別市場佔有率
第11章 專利分析
第12章 避免死胎所需之胎兒監測及產前診斷
第13章 目前情形及市場展望
第14章 企業簡介
第15章 附錄
圖表
Abstract
REPORT HIGHLIGHTSTHIS
REPORT CONTAINS
- An overview of the market for fetal monitoring, diagnostics, and
predictive tests
- Analysis of market trends, with data from 2009, estimates for 2010, and
projections of compound annual growth rates (CAGRs) through 2015
- A breakdown of the fetal monitoring segment, including electronic
monitors, handheld Doppler devices, telemetry monitoring, amnioscopy, and
infant heart rate and apnea monitoring; and the diagnostics segment, including
ultrasound, X-rays, chorionic villus sampling, alpha-fetoprotein testing, and
pregnancy confirmation testing.
- Discussions of regulatory issues and new developments
- Comprehensive company profiles and patent analyses
REPORT SCOPE
INTRODUCTION
STUDY OBJECTIVES
BCC' s goal in conducting this study is to provide an overview of the current
and future characteristics of the global market for fetal monitoring and
diagnosis, including neonatal monitoring. The key objective is to present a
comprehensive analysis of the current market and its future direction in the
fetal and neonatal monitoring market with the utilization of the techniques
and devices available for preventing fetal diseases.
This report explores present and future strategies within the fetal monitoring
and diagnosis market, including prenatal and neonatal monitoring and
diagnosis. The market' s current state, its setbacks, its innovations, and its
future needs are discussed in this report. A general overview of fetus
testing techniques and devices, as well as related technologies used currently
and in the past, are discussed in this report.
A detailed analysis of the fetal and neonatal monitoring and diagnosis
industry structure has been conducted. This includes all the categories of
monitoring and diagnosis broken down by market share that belong to leading
manufacturers and/or suppliers. Revenues for each of the categories are
broken down by region. Sales figures are estimated for the 5-year period from
2011 through 2016.
Applications for fetal monitoring and diagnosis, (including neonatal
monitoring) for usage in antepartum and intrapartum are also discussed
separately in the report by region. The markets in diagnosing cardiopulmonary
diseases in neonates are also studied. The report includes significant
patents and their allotments in each category of fetal monitoring and
diagnosis.
REASONS FOR DOING THIS STUDY
This study was conducted to provide vital and detailed information regarding
fetal and neonatal monitoring and diagnosing. This industry is experiencing
growth, as the concept of fetus as a patient has changed the entire industry.
Technological advancements have made it possible to access and monitor the
fetus. This study was conducted to provide detailed analysis of the market
along with the different factors that affect it. The rising number of
high-risk pregnancies is placing greater demands of advanced fetal - maternal
monitoring during both the antepartum and intrapartum delivery of care during
pregnancy.
Acquisitions, mergers, and alliances by companies and global organizations are
covered in this report. The study also discusses the strengths and weaknesses
of each category of fetal monitoring and diagnosis in addition to new
technologies and developments, manufacturer and supplier competition, and the
changing environment of the market due to the increasing awareness of
expectant mothers.
INTENDED AUDIENCE
This study contributes to the areas of market growth in the arena of devices
and predictive tests used during various stages of pregnancy that may help
prevent some diseases through early detection. It will be of interest to
clinicians, physicians, the pharmaceutical and biopharmaceutical industries,
hospitals, and research institutions.
SCOPE OF THE STUDY
The scope of this study encompasses the fetal monitoring and diagnostics
markets. BCC analyzes each market and its applications by its need for usage
in different stages of pregnancy, along with the regulatory environment,
technology involved, market projections, and market share. Technological
issues include the latest trends and developments.
METHODOLOGY
Both primary and secondary research methodologies were used in preparing this
study. BCC conducted a comprehensive literature search that included
technical newsletters and journals, as well as many other sources. Data were
collected through interviews and correspondence with various pharmaceutical
and biotechnical experts. Projections were based on estimates such as the
current number of end users, potential end users, mergers and acquisitions,
and market trends.
INFORMATION SOURCES
Many companies within the industry were surveyed to obtain data for this
study. Also included were manufacturers, end users of pharmaceuticals and
devices, and hospitals. Data were gathered from various industry sources.
BCC spoke with officials and physicians within the industry, and also
consulted newsletters, company literature, product literature, technical
articles, journals, indexes, and abstracts. Exhaustive investigations of
databases by key terminology were completed. In addition, data were compiled
from current financial, trade, and government sources.
ABOUT THE AUTHOR
The study has been carried out by a team of professionals in the biotechnology
industry. The project manager is Shalini S. Dewan, who holds a Master' s
degree in Pharmaceutical Chemistry and has more than 14 years of industry
experience. Among the research topics she has covered are studies on
compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl
acetic acid. Shalini was awarded a Gold Medal by the Prime Minister of India
for her work and has worked with top companies in India and the U.S. Her
other reports with BCC Research include Reagents of Chromatography;
Spectroscopy, an Enduring Market; Advanced Drug Delivery Systems: New
Developments, New Technologies; Orthopedic Drugs, Implants and Devices;
Pharmaceutical Regulatory Industry; The Dynamic Media, Sera and Reagent Market
in Biotechnology; Contract Pharmaceutical Manufacturing, Research and
Packaging; Chiral Technology: Global Markets; Autacoids and Related Drugs:
Technologies and Global Markets; Contraceptives: Technologies and Global
Markets; Liver Disease Treatments: The Global Market; Hormone Replacement
Therapies and Other Hormone Therapies: Global Markets; Cardiovascular
Medicine: Diagnostics, Drugs and Devices; Cancer Therapies: Technologies and
Global Markets; and Medical Imaging Reagents and Analysis Equipment.
The lead consultant for this project was Dr. Kapil A. Setia, who holds a
doctoral degree in Life Sciences. She has a number of research publications
to her credit, including her thesis on Studies on Phenotypic Variation, Clonal
Propagation, and Phyto-chemistry of Tinospora cordifolia (Willd.).
Table of Contents
Chapter- 1: INTRODUCTION - Complimentary
- Hide Details
- STUDY OBJECTIVES
- REASONS FOR DOING THIS STUDY
- INTENDED AUDIENCE
- SCOPE OF THE STUDY
- METHODOLOGY
- INFORMATION SOURCES
- ABOUT THE AUTHOR
- RELATED BCC RESEARCH REPORTS
- BCC ONLINE SERVICES
- DISCLAIMER
Chapter- 2: EXECUTIVE SUMMARY
- Hide Details
- Table 0 : GLOBAL REVENUE OF FETAL MONITORING AND DIAGNOSIS, THROUGH 2016
- Figure 0 : GLOBAL REVENUE OF FETAL MONITORING AND DIAGNOSIS, 2009-2016
Chapter- 3: OVERVIEW
- Hide Details
- DEFINITIONS
- TYPES OF FETAL MONITORING
- TYPES OF FETAL MONITORS
- PRENATAL DIAGNOSIS
Chapter- 4: REGULATORY ASPECTS
- Hide Details
- PREMARKET CLEARANCE AND 510(K) CLEARANCES
- Table 5 : PRE-MARKET APPROVALS, 2006 TO DECEMBER 2010
Chapter- 5: CLASSIFICATION
- Hide Details
- FETAL MONITORING
- PRENATAL DIAGNOSIS
- NEONATAL MONITORING
Chapter- 6: TESTS FOR GENETIC DISORDERS
- Hide Details
- DOMINANT GENE DISORDERS
- RECESSIVE GENE DISORDERS
- X-LINKED DISORDERS
- CHROMOSOMAL DISORDERS
Chapter- 7: INDUSTRY STRUCTURE
- Hide Details
- MANUFACTURERS AND SUPPLIERS OF FETAL MONITORS AND DIAGNOSTIC INSTRUMENTS
- MARKET SHARES OF INDUSTRY LEADERS OF FETAL MONITORING SYSTEMS AND
DIAGNOSTICS
Chapter- 8: NEW DEVELOPMENTS
Chapter- 9: MARKET ANALYSIS
- Hide Details
- MARKET REVENUE
- FETAL MONITORING
- PRENATAL DIAGNOSTICS
Chapter- 10: MARKET BY APPLICATIONS
- Hide Details
- ANTEPARTUM FETAL MONITORING
- INTRAPARTUM FETAL MONITORING
- NEONATAL MONITORING FOR CARDIOPULMONARY DISEASES
- MARKET SHARE OF APPLICATIONS
- Table 34 : SHARES OF VARIOUS CATEGORIES OF FETAL MONITORING AND
DIAGNOSIS BY APPLICATION, 2010
- Figure 22 : SHARE OF VARIOUS CATEGORIES OF FETAL MONITORING AND
DIAGNOSIS BY APPLICATION, 2010
Chapter- 11: PATENT ANALYSIS
- Hide Details
- PATENTS BY YEAR
- PATENTS BY TYPE
- PATENTS BY COMPANY
- PATENTS BY COUNTRY
- PATENTS BY ASSIGNEE
Chapter- 12: FETAL MONITORING AND PRENATAL DIAGNOSTICS TO HELP REDUCE STILLBIRTHS
Chapter- 13: CURRENT SITUATION AND MARKET PROSPECTS
- Hide Details
- FACTORS AFFECTING THE MARKET
- FUTURE PROSPECTS OF THE MARKETS
Chapter- 14: COMPANY PROFILES
- Hide Details
- ALIMED INC.
- ALLEN MEDICAL INSTRUMENTS CORPORATION
- ANALOGIC CORPORATION
- ATOM MEDICAL CORPORATION
- BIONET AMERICA INC.
- CARDINAL HEALTH
- CAREFUSION CORPORATION
- CAS MEDICAL SYSTEMS, INC.
- CLINICAL INNOVATIONS, INC.
- COOPER SURGICAL, INC.
- COVIDIEN
- DRE MEDICAL EQUIPMENTS
- ESAOTE SA
- FONAR CORPORATION
- GE HEALTHCARE
- GIMA PROFESSIONAL MEDICAL PRODUCTS
- HITACHI MEDICAL SYSTEMS, INC.
- ARJOHUNTLEIGH
- MASIMO CORPORATION
- MED-ELECTRONICS, INC.
- MEDISON AMERICA, INC.
- MEDLINE INDUSTRIES
- NEOVENTA MEDICAL, INC.
- NIHON KOHDEN CORPORATION
- NONIN MEDICAL, INC.
- PARAMED MEDICAL SYSTEMS
- PHILIPS HEALTHCARE
- ROCKET MEDICAL, PLC
- SHENZHEN OSEN TECHNOLOGY CO., LTD.
- SHIMADZU EUROPE, GMBH
- SIEMENS HEALTHCARE
- SONOSITE, INC.
- SUMMIT DOPPLER
- SUNRAY MEDICAL APPARATUS COMPANY, LTD.
- SUPERIOR MEDICAL, LTD.
- TERASON ULTRASOUND
- THAMES MEDICAL, LTD.
- TOSHIBA AMERICA MEDICAL SYSTEMS, INC.
- UTAH MEDICAL PRODUCTS, INC.
- WALLACH SURGICAL DEVICES, INC.
Chapter- 15: APPENDIX I: ABBREVIATIONS AND DEFINITIONS
List of Tables
- Summary Table : GLOBAL REVENUE OF FETAL MONITORING AND DIAGNOSIS, THROUGH
2016
- Table 1 : ADVANTAGES AND DISADVANTAGES OF EXTERNAL FETAL MONITORING
- Table 2 : ADVANTAGES AND DISADVANTAGES OF INTERNAL FETAL MONITORING
- Table 3 : EXTERNAL FETAL MONITORING VERSUS INTERNAL FETAL MONITORING
- Table 4 : ULTRASOUND VERSUS MRI
- Table 5 : PRE-MARKET APPROVALS, 2006 TO DECEMBER 2010
- Table 6 : LEADING MANUFACTURERS AND SUPPLIERS OF FETAL DOPPLERS
- Table 7 : LEADING MANUFACTURERS AND SUPPLIERS OF FETAL MONITORS
- Table 8 : LEADING MANUFACTURERS AND SUPPLIERS OF FETAL SCALP ELECTRODES,
FETOSCOPES, AND CATHETERS
- Table 9 : LEADING MANUFACTURERS AND SUPPLIERS OF ULTRASOUND SYSTEMS
- Table 10 : LEADING MANUFACTURERS AND SUPPLIERS OF MRI SYSTEMS
- Table 11 : LEADING MANUFACTURERS AND SUPPLIERS OF NEONATAL SYSTEMS
- Table 12 : GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF FETAL
DOPPLERS, 2010
- Table 13 : GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF FETAL
MONITORS, 2010
- Table 14 : GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF OTHER
FETAL MONITORING DEVICES, 2010
- Table 15 : GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF
ULTRASOUND SYSTEMS IN FETAL MONITORING AND DIAGNOSIS, 2010
- Table 16 : GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF MAGNETIC
RESONANCE IMAGING SYSTEMS USED IN FETAL MONITORING AND DIAGNOSIS, 2010
- Table 17 : GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF NEONATAL
MONITORING SYSTEMS, 2010
- Table 18 : NEW DEVELOPMENTS, 2008 - FEBRUARY 2011
- Table 19 : GLOBAL MARKET FOR FETAL MONITORING AND DIAGNOSTICS BY REGION,
THROUGH 2016
- Table 20 : GLOBAL MARKET FOR FETAL DOPPLERS BY REGION, THROUGH 2016
- Table 21 : GLOBAL MARKET FOR FETAL MONITORS BY REGION, THROUGH 2016
- Table 22 : GLOBAL MARKET FOR OTHERS CATEGORY OF FETAL MONITORING BY
REGION, THROUGH 2016
- Table 23 : GLOBAL MARKET FOR PRENATAL MONITORING BY ULTRASOUND AND
ULTRASONOGRAPHY BY REGION, THROUGH 2016
- Table 24 : GLOBAL MARKET FOR PRENATAL MONITORING BY MAGNETIC RESONANCE
IMAGING BY REGION, THROUGH 2016
- Table 25 : GLOBAL MARKET FOR PRENATAL MONITORING BY AMNIOCENTESIS AND
CHORIONIC VILLUS SAMPLING BY REGION, THROUGH 2016
- Table 26 : GLOBAL MARKET FOR PRENATAL MONITORING BY SCREENING AND OTHER
TESTS BY REGION, THROUGH 2016
- Table 27 : GLOBAL MARKET FOR NEONATAL MONITORING BY REGION, THROUGH 2016
- Table 28 : GLOBAL FETAL MONITORING AND DIAGNOSTICS MARKET SHARES BY
REGION, 2010
- Table 29 : GLOBAL MARKET FOR ANTEPARTUM MONITORING AND DIAGNOSTICS,
THROUGH 2016
- Table 30 : GLOBAL MARKET FOR INTRAPARTUM MONITORING AND DIAGNOSTICS,
THROUGH 2016
- Table 31 : GLOBAL MARKET FOR NEONATAL MONITORING FOR CARDIOPULMONARY
DISEASES, THROUGH 2016
- Table 32 : GLOBAL MARKET FOR NEONATAL MONITORING FOR CONGENITAL HEART
DISEASES, THROUGH 2016
- Table 33 : GLOBAL MARKET FOR NEONATAL MONITORING FOR PULMONARY DISEASES,
THROUGH 2016
- Table 34 : SHARES OF VARIOUS CATEGORIES OF FETAL MONITORING AND DIAGNOSIS
BY APPLICATION, 2010
- Table 35 : SIGNIFICANT PATENTS BY YEAR, 2007 - 2011
- Table 36 : PATENTS BY TYPE, 2007 - 2011
- Table 37 : U.S. PATENTS BY COMPANY FOR FETAL MONITORING, 2007 - 2011
- Table 38 : U.S. PATENTS FOR PRENATAL DIAGNOSIS BY COMPANY, 2007 - 2011
- Table 39 : U.S. PATENTS FOR NEONATAL MONITORING BY COMPANY, 2007 - 2011
- Table 40 : U.S. PATENTS FOR FETAL MONITORING BY COUNTRY, 2007 - 2011
- Table 41 : U.S. PATENTS FOR PRENATAL DIAGNOSIS BY COUNTRY, 2007 - 2011
- Table 42 : U.S. PATENTS FOR NEONATAL MONITORING BY COUNTRY, 2007 - 2011
- Table 43 : U.S. PATENTS FOR ALL FETAL AND NEONATAL MONITORING AND
DIAGNOSIS BY COUNTRY, 2007 - 2011
- Table 44 : PATENTS FOR FETAL MONITORING BY ASSIGNEE TYPE, 2007 - 2011
- Table 45 : PATENTS FOR PRENATAL DIAGNOSIS BY ASSIGNEE TYPE, 2007 - 2011
- Table 46 : PATENTS FOR NEONATAL MONITORING BY ASSIGNEE TYPE, 2007 - 2011
List of Figures
- Summary Figure : GLOBAL REVENUE OF FETAL MONITORING AND DIAGNOSIS,
2009-2016
- Figure 1 : GLOBAL REVENUE OF FETAL MONITORING AND DIAGNOSIS, 2009-2016
- Figure 2 : GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF FETAL
MONITORS, 2010
- Figure 3 : GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF OTHER
FETAL MONITORING DEVICES, 2010
- Figure 4 : GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF
ULTRASOUND SYSTEMS IN FETAL MONITORING AND DIAGNOSIS, 2010
- Figure 5 : GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF MAGNETIC
RESONANCE IMAGING IN FETAL MONITORING AND DIAGNOSIS, 2010
- Figure 6 : GLOBAL MARKET SHARES OF MANUFACTURERS AND SUPPLIERS OF NEONATAL
MONITORING SYSTEMS, 2010
- Figure 7 : GLOBAL MARKET FOR FETAL MONTINORING AND DIAGNOSTICS BY REGION,
2009-2016
- Figure 8 : GLOBAL MARKET FOR FETAL DOPPLERS BY REGION, 2009-2016
- Figure 9 : GLOBAL MARKET FOR FETAL MONITORS BY REGION, 2009-2016
- Figure 10 : GLOBAL MARKET FOR OTHERS CATEGORY FOR FETAL MONITORING BY
REGION, 2009-2016
- Figure 11 : GLOBAL MARKET FOR PRENATAL MONITORING BY ULTRASOUND AND
ULTRASONOGRAPHY BY REGION, 2009-2016
- Figure 12 : GLOBAL MARKET FOR PRENATAL MONITORING BY MAGENTIC RESONANCE
IMAGING BY REGION, 2009-2016
- Figure 13 : GLOBAL MARKET FOR PRENATAL MONITORING BY AMNIOCENTESIS AND
CHRIONIC VILLUS SAMPLING BY REGION, 2009-2016
- Figure 14 : GLOBAL MARKET FOR PRENATAL MONITORING BY SCREENING AND OTHER
TESTS BY REGION, 2009-2016
- Figure 15 : GLOBAL MARKET FOR NEONATAL MONITORING BY REGION, 2009-2016
- Figure 16 : GLOBAL FETAL MONITORING AND DIAGNOSTICS MARKET SHARES BY
REGION, 2010
- Figure 17 : GLOBAL MARKET FOR ANTEPARTUM MONITORING AND DIAGNOSTICS,
2009-2016
- Figure 18 : GLOBAL MARKET FOR INTRAPARTUM MONITORING AND DIAGNOSTICS,
2009-2016
- Figure 19 : GLOBAL MARKET FOR NEONATAL MONITORING FOR CARDIOPULMONARY
DISEASES, 2009-2016
- Figure 20 : GLOBAL MARKET FOR NEONATAL MONITORING FOR CONGENIATAL HEART
DISEASE, 2009-2016
- Figure 21 : GLOBAL MARKET FOR NEONATAL MONITORING FOR PULMONARY DISEASES,
2009-2016
- Figure 22 : SHARE OF VARIOUS CATEGORIES OF FETAL MONITORING AND DIAGNOSIS
BY APPLICATION, 2010
- Figure 23 : PATENTS BY YEAR, 2007 - 2011
- Figure 24 : PATENTS BY YEAR, 2007 - 2011
- Figure 25 : TOTAL PATENTS BY TYPE, 2007 - 2011
- Figure 26 : U.S. PATENTS FOR PRENATAL DIAGNOSIS BY COUNTRY, 2007 - 2011
- Figure 27 : PATENT SHARES FOR ALL FETAL AND NEONATAL MONITORING AND
DIAGNOSIS BY COUNTRY, 2007 - 2011
- Figure 28 : PATENTS FOR FETAL MONITORING BY ASSIGNEE TYPE, 2007 - 2011
- Figure 29 : PATENTS FOR PRENATAL DIAGNOSIS BY ASSIGNEE TYPE, 2007 - 2011
|
 |
